{
    "2018-01-19": [
        [
            {
                "time": "2018-01-19",
                "original_text": "智通港股公告精选︱1月19日",
                "features": {
                    "keywords": [
                        "港股",
                        "公告",
                        "精选"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "首届金骏马奖揭晓 长盛基金揽双项大奖",
                "features": {
                    "keywords": [
                        "金骏马奖",
                        "长盛基金",
                        "大奖"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "复星医药：第七届董事会第五十一次会议(临时会议)决议公告",
                "features": {
                    "keywords": [
                        "复星医药",
                        "董事会",
                        "决议"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "复星医药(02196)经总裁提名 聘任李东明为公司副总裁",
                "features": {
                    "keywords": [
                        "复星医药",
                        "聘任",
                        "副总裁"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "最被看好十大港股：麦格理维持腾讯目标价450元",
                "features": {
                    "keywords": [
                        "港股",
                        "腾讯",
                        "目标价"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "CAR-T新药获实质进展 银河生物今日复牌",
                "features": {
                    "keywords": [
                        "CAR-T",
                        "新药",
                        "银河生物",
                        "复牌"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "高盛升复星医药(02196.HK)评级至「买入」 上调三生制药(01530.HK)目标价",
                "features": {
                    "keywords": [
                        "高盛",
                        "复星医药",
                        "三生制药",
                        "买入",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "42家药企上榜2017中国上市公司市值500强",
                "features": {
                    "keywords": [
                        "药企",
                        "市值",
                        "500强"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "基金经理看好宏观景气 继续力挺蓝筹",
                "features": {
                    "keywords": [
                        "基金经理",
                        "宏观景气",
                        "蓝筹"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "盘前有料 | 银行业绩改善+估值重构 机构看好这些股",
                "features": {
                    "keywords": [
                        "银行业",
                        "业绩改善",
                        "估值重构"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "最牛基金经理持仓曝光：兴全谢治宇、东方红林鹏十大重仓股抢先看",
                "features": {
                    "keywords": [
                        "基金经理",
                        "持仓",
                        "兴全",
                        "谢治宇",
                        "东方红",
                        "林鹏"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "三元股份联手复星拓展大健康产业",
                "features": {
                    "keywords": [
                        "三元股份",
                        "复星",
                        "大健康"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "[晨会聚焦]经济短期回暖",
                "features": {
                    "keywords": [
                        "晨会",
                        "经济",
                        "短期回暖"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "强生欲剥离糖尿病业务 三诺生物等或40亿美元参与竞购",
                "features": {
                    "keywords": [
                        "强生",
                        "糖尿病",
                        "三诺生物",
                        "竞购"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}